A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：CLINICAL EPIGENETICS ISSN： 1868-7075 出版频率： Continuous publication 出版社： BMC, CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW   出版社网址： https://www.biomedcentral.com/ 期刊网址： https://clinicalepigeneticsjournal.biomedcentral.com/ 影响因子： 6.551 主题范畴： ONCOLOGY;    GENETICS & HEREDITY 变更情况： Newly Added by 2019 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Aims and scope Encompassing the broad spectrum of epigenetics research from basic research to innovations in therapeutic treatments, Clinical Epigenetics is a top tier, open access journal devoted to the study of epigenetic principles and mechanisms as applied to human development, disease, diagnosis and treatment. The journal particularly welcomes submissions involving clinical trials, translational research, new and innovative methodologies and model organisms providing mechanistic insights. The journal is divided into the following sections: Aging and development epigenetics Allergy, immunology, and pathogen epigenetics Cancer epigenetics and diagnostics Cardiovascular epigenetics Endocrinology and metabolic epigenetics Environmental epigenetics Epigenetic biomarkers Epigenetic technologies Epigenetic drugs and clinical trials Innovative therapies Lifestyle epigenetics Neurology and psychiatry epigenetics Regenerative medicine Reproductive and transgenerational epigenetics For more information on the the section aims and scope visit our section information page. If you are unclear which section would be best suited to your submission, we invite you to submit a pre-submission inquiry by selecting the Contact Us option here. Editorial Policy on Submissions Involving RNAs Differential RNA expression levels (coding or non-coding) or RNA modifications cannot be considered as part of epigenetics, and this includes levels of the RNA modifying enzymes or readers. The fact that non-coding RNAs might affect other genes at their RNA level classifies these molecules as post-transcriptional gene expression regulators. Although modification of RNAs resembles modifications of DNA or histone proteins, so do post-translational modifications of various proteins. As such, RNAs modifiers as a class of regulators are not different from protein-modifiers, which also are not considered part of epigenetics per se.  For manuscripts on non-coding RNAs to be considered for publication in Clinical Epigenetics, the authors must provide at least one of the following: data on the molecular epigenetic regulation of the expression of non-coding RNA (or its modifying enzymes); or insights on the mechanism of action of the non-coding RNA on the functioning of the DNA; or insights in mitotic stability of the RNA-induced effect. Open access All articles published by Clinical Epigenetics are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here. As authors of articles published in Clinical Epigenetics you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement. For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed. Article-processing charges Open access publishing is not without costs. Clinical Epigenetics therefore levies an article-processing charge of £2290.00/$3170.00/€2570.00 for each article accepted for publication, plus VAT or local taxes where applicable. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page. BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service. Indexing services All articles published in Clinical Epigenetics are included in: Academic OneFile CAS DOAJ Journal Citation Reports/Science Edition OCLC Medline PubMed PubMed Central Science Citation Index Expanded Scopus Summon by Serial Solutions The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink. Instructions to Authors Our 3-step submission process   Before you submit Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit. Make sure you are submitting to the most suitable journal - Aims and scope Understand the costs and funding options - Fees and funding Make sure your manuscript is accurate and readable - Language editing services Understand the copyright agreement - Copyright   Ready to submit To give your manuscript the best chance of publication, follow these policies and formatting guidelines. General formatting rules for all article types - Preparing your manuscript Make sure your submission is complete - Prepare supporting information Copyright and license agreement - Conditions of publication Read and agree to our Editorial Policies - Editorial policies   Submit and promote After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond. Please note that manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.  Who decides whether my work will be accepted? - Peer-review policy Want to submit to a different journal? - Manuscript transfers Spreading the word - Promoting your publication Submit manuscript Editorial Board Editors-in-Chief Lucia Altucci, Università degli Studi della Campania, Italy  Marianne Rots, University Medical Center Groningen, The Netherlands  Founding Editor Ulrich Mahlknecht, St Lukas Clinic, Solingen, Germany  Advisory Board Rui Henrique, Portuguese Oncology Institute of Porto and Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal Holger Heyn, National Center for Genomic Analysis, Center for Genomic Regulation (CNAG-CRG), Barcelona Institute of Science and Technology (BIST), Spain Jean-Pierre Issa, Coriell Institute for Medical Research, USA Caroline Relton, University of Bristol, UK Hendrik (Henk) G Stunnenberg, Princess Máxima Center for Pediatric Oncology, Utrecht and Radboud University Nijmegen, The Netherlands Saad Z Usmani, Levin Cancer Institute, University of North Carolina-Chapel Hill, School of Medicine, USA Aging and development epigenetics Section Editor:  Akihiro Umezawa, National Institute for Child Health and Development, Japan Associate Editors:  Koichiro Nishino, University of Miyazaki, Japan Monika Puzianowska-Kuznicka, Mossakowski Medical Research Centre, Poland Wolfgang Wagner, Aachen University Medical School, Germany Allergy, immunology, pathogens and inflammation Section Editor: Georges Herbein, University of Franche-Comté, France  Associate Editor: Kari Nadeau, Stanford University, USA Cancer epigenetics and diagnostics Section Editors: Maria Berdasco, Joseph Carreras Leukemia Research Institute (IJC), Spain  Carmen Jerónimo, Portuguese Oncology Institute of Porto (IPO Porto) & University of Porto, Portugal  Associate Editors: Nita Ahuja, Yale University, USA  James M Flanagan, Imperial College London, UK Mario F Fraga, Nanomaterials and Nanotechnology Center (CINN-CSIC), Health Research Institute of Asturias (ISPSA), Institute of Oncology of Asturias (IUOPA, University of Oviedo), Spain Michèle J Hoffmann, Heinrich-Heine-University Duesseldorf, Germany Bozena Kaminska, Nencki Institute of Experimental Biology, Poland Jonathan Licht, The University of Florida, USA Gwen Lomberk, Medical College of Wisconsin, USA Arpad Patai, Semmelweis University, Hungary Qian Tao, The Chinese University of Hong Kong, Hong Kong Raul Urrutia, Genomics Sciences and Precision Medicine Center, Medical College of Wisconsin, USA  Keishi Yamashita, Kitasato University, Japan Cardiovascular epigenetics Associate Editor: Ronan Murphy, Dublin City University, Ireland Endocrinology and metabolic epigenetics Section Editor: Sam El-Osta, Monash University, Australia Associate Editors: Charlotte Ling, Lund University, Sweden Richard Saffery, Murdoch Childrens Research Institute, Australia  Environmental epigenetics Section Editor:  Steven Gray, St James's Hospital, Ireland  Associate Editor: Boris Novakovic, Murdoch Children's Research Institute, Australia Epigenetic biomarkers Section Editor: Marianne Rots, University Medical Center Groningen, The Netherlands  Associate Editor: Dawn L. DeMeo, Brigham and Women's Hospital/ Harvard Medical School, USA Harold Snieder, University Medical Center Groningen, The Netherlands Tomasz K Wojdacz, Pomeranian Medical University, Poland Epigenetic technologies Section Editor: Jim Davie, University of Manitoba, Canada Associate Editor: Albert Jeltsch, University of Stuttgart, Germany  Epigenetic therapies and clinical trials Section Editors: Paola Arimondo, Centre National de la Recherche Scientifique, Institut Pasteur, France Richard Momparler, University of Montreal, Canada Associate Editors: Nick La Thangue, University of Oxford, UK Antonello Mai, "Sapienza" Universitá di Roma, Italy Innovative epigenetic therapies Section Editor:  David Jay Segal, University of California-Davis, USA Lifestyle epigenetics Section Editor: Wim Vanden Berghe, University of Antwerp, Belgium Neurology and psychiatry epigenetics Section Editors: Jonathan Mill, University of Exeter and King's College London, UK  Moshe Szyf, McGill University, Canada  Associate Editor: Riccardo Marioni, University of Edinburgh, UK Jonathan Turner, Luxembourg Institute of Health, Luxembourg Regenerative medicine Section Editor: Adele Murrell, University of Bath, UK Associate Editor: Peter Rugg-Gunn, The Babraham Institute, University of Cambridge, UK Reproductive and transgenerational epigenetics Section Editor:  Eamonn Maher, University of Cambridge, UK Associate Editor: Miguel Constancia, University of Cambridge, UK Gavin Kelsey, The Babraham Institute and Centre for Trophoblast Research, University of Cambridge, UK Statisticians Lingeng Lu, Yale University, USA Harold Snieder, University Medical Center Groningen, The Netherlands Editorial Board Lorena Aguilar Arnal, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México Alfonso Baldi, Università della Campania Luigi Vanvitelli, Italy Steven Belinsky, Lovelace Respiratory Research Institute, USA  Rosaria Bennedeti, Universitá degli Studi della Campania "Luigi Vanvitelli", Italy Francesco Bertoni, Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Switzerland Nathalie Bérubé, Western University, Canada Pilar Blancafort, The Harry Perkins Institute of Medical Research & University of Western Australia, Australia Tiziana Bonaldi, European Institute of Oncology, Italy  Miguel Branco, Queen Mary University of London, UK Robert Brown, Imperial College London, UK Kyle J Burghardt, Wayne State University, USA Andres Cardenas, University of California, Berkeley, USA Katherine Chiappinelli, George Washington University, USA James Chim, University of Hong Kong, Hong Kong  Gianluigi Condorelli, Humanitas University, Italy Rene Cortese, University of Missouri, USA Christos Damaskos, University of Athens, Greece Soner Dogan, Yeditepe University, Turkey Tomas J Ekström, Karolinska Institutet, Sweden  Thomas Eggermann, RWTH Aachen, Germany  Karl Ekwall, Karolinska Institutet, Sweden  Frank O Fackelmayer, Institute of Molecular Biology and Biotechnology IMBB-Forth, Greece Mirco Fanelli, University of Urbino "Carlo Bo," Italy Robert Feil, CNRS and University of Montpellier, France Roger Foo, Genome Institute of Singapore, Singapore François Fuks, Univerité libre de Bruxelles, Belgium Peter Gluckman, The Liggins Institute of Medical Research, New Zealand  Joel Gottesfeld, The Scripps Research Institute, USA  Monika Hegi, Lausanne University Hospital, Switzerland John W Holloway, University of Southampton, UK Ricky Johnstone, Peter MacCallum Cancer Centre, Australia  Meaghan Jones, The University of British Columbia, Canada Masayo Kagami, National Research Institute for Child Health and Development, Japan Yutaka Kondo, Nagoya City University Graduate School of Medical Sciences, Japan  Ah-Ng Tony Kong, Rutgers University, USA Michele A La Merrill, University of California-Davis, USA Andy Lau, Shantou University Medical College, China Haitao Li, Tsinghua University, China Lili Li, The Chinese University of Hong Kong, Hong Kong Michael Lübbert, Universitätsklinikum Freiburg, Germany Deborah JG Mackay, Southampton University Hospital, UK Joost Martens, Radboud Institute for Molecular Life Sciences, The Netherlands Patrick O McGowan, University of Toronto, Canada  Saverio Minucci, IFOM - IEO, Italy  David Monk, Institut d'Investigació Biomèdica Bellvitge, Spain  Pamela Munster, University of California, USA Clara Nervi, University of Rome La Sapienza, Italy  Andreas Neubauer, Philipps Universität Marburg, Germany  Stephen Nimer, University of Miami, USA  Miina Ollikainen, University of Helsinki, Finland Jan Postberg, Witten/Herdecke University, Germany H Llewelyn Roderick, KU Leuven, Belgium Olivier Rohr, University of Strasbourg, France Paola Scaffidi, The Francis Crick Institute and UCL Cancer Institute, UK Huidong Shi, Georgia Cancer Center, Medical College of Georgia, Augusta University, USA Toshihiro Shioda, Massachusetts General Hospital Center for Cancer Research and Harvard Medical School, USA Gustavo Turecki, McGill University, Canada  Toshikazu Ushijima, National Cancer Center Research Institute, Japan  Carine Van Lint, University of Brussels (ULB), Belgium  Eric Verdin, J David Gladstone Institutes, USA Aleksandar Vojta, University of Zagreb, Croatia Stefan Wiemann, German Cancer Research Center-Heidelberg (DKFZ), Germany Bea Wisman, University Medical Center Groningen, The Netherlands Olaf Witt, German Cancer Research Center, Germany  Suowen Xu, University of Rochester Medical Center, USA Elisabeth Zeisberg, University Medical Center Göttingen, Germany Vlatka Zoldos, University of Zagreb, Croatia